Contribution of enhanced engagement of antigen presentation machinery to the clinical immunogenicity of a human interleukin (IL)-21 receptor-blocking therapeutic antibody
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Contribution of enhanced engagement of antigen presentation machinery to the clinical immunogenicity of a human interleukin (IL)-21 receptor-blocking therapeutic antibody
Authors
Keywords
-
Journal
CLINICAL AND EXPERIMENTAL IMMUNOLOGY
Volume 183, Issue 1, Pages 102-113
Publisher
Wiley
Online
2015-09-24
DOI
10.1111/cei.12711
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Interleukin-21: a double-edged sword with therapeutic potential
- (2014) Rosanne Spolski et al. NATURE REVIEWS DRUG DISCOVERY
- Aggregation of Human Recombinant Monoclonal Antibodies Influences the Capacity of Dendritic Cells to Stimulate Adaptive T-Cell Responses In Vitro
- (2014) Verena Rombach-Riegraf et al. PLoS One
- B-cell memory and primary immune deficiencies
- (2013) Marylin Desjardins et al. Current Opinion in Allergy and Clinical Immunology
- Controlling immune responses by targeting antigens to dendritic cell subsets and B cells
- (2013) Craig P. Chappell et al. INTERNATIONAL IMMUNOLOGY
- Anti-IL21 receptor monoclonal antibody (ATR-107): Safety, pharmacokinetics, and pharmacodynamic evaluation in healthy volunteers: A phase I, first-in-human study
- (2013) Fei Hua et al. JOURNAL OF CLINICAL PHARMACOLOGY
- IL-21 Enhances Phagocytosis in Mononuclear Phagocyte Cells: Identification of Spleen Tyrosine Kinase as a Novel Molecular Target of IL-21
- (2013) F. Vallieres et al. JOURNAL OF IMMUNOLOGY
- T Follicular Helper Cells Mediate Expansion of Regulatory B Cells via IL-21 in Lupus-Prone MRL/lpr Mice
- (2013) Xue Yang et al. PLoS One
- The nature of activatory and tolerogenic dendritic cell-derived signal II
- (2013) Ghaith Bakdash et al. Frontiers in Immunology
- Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions
- (2012) Ayumi Yoshizaki et al. NATURE
- Considerations for optimization and validation of an in vitro PBMC derived T cell assay for immunogenicity prediction of biotherapeutics
- (2010) Danika Wullner et al. CLINICAL IMMUNOLOGY
- IL-21 Receptor Is Critical for the Development of Memory B Cell Responses
- (2010) A. L. Rankin et al. JOURNAL OF IMMUNOLOGY
- Assessing agonistic potential of a candidate therapeutic anti-IL21R antibody
- (2010) Yongjing Guo et al. Journal of Translational Medicine
- In vitro potency, pharmacokinetic profiles and pharmacological activity of optimized anti-IL-21R antibodies in a mouse model of lupus
- (2010) Yulia Vugmeyster et al. mAbs
- The immunogenicity of humanized and fully human antibodies
- (2010) Fiona A. Harding et al. mAbs
- Endosomal sorting of MHC class II determines antigen presentation by dendritic cells
- (2008) Guillaume van Niel et al. CURRENT OPINION IN CELL BIOLOGY
- Dendritic cells and cytokines in human inflammatory and autoimmune diseases
- (2008) P BLANCO et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Dendritic Cells In Vivo: A Key Target for a New Vaccine Science
- (2008) Ralph M. Steinman IMMUNITY
- Interleukin 21: a cytokine/cytokine receptor system that has come of age
- (2008) Warren J. Leonard et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Interleukin-21: Basic Biology and Implications for Cancer and Autoimmunity
- (2007) Rosanne Spolski et al. Annual Review of Immunology
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now